Intraperitoneal Radioimmunochemotherapy of Ovarian Cancer: A Phase I Study-Reference-Cited by-同舟云学术

Intraperitoneal Radioimmunochemotherapy of Ovarian Cancer: A Phase I Study

Published:2001-08 Issue:4 Volume:16 Page:305-315
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Meredith Ruby F.¹,Alvarez Ronald D.²,Partridge Edward E.²,Khazaeli M.B.³,Lin Chin-Yu⁴,Macey Daniel J.¹,Austin J. Maxwell²,Kilgore Larry C.²,Grizzle William E.⁵,Schlom Jeffrey⁶,LoBuglio Albert F.³

Affiliation:

1. Department of Radiation Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL

2. Department of Obstetrics & Gynecology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL

3. Department of Medicine, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL

4. Bristol-Myers Squibb Company, Wallington, CT

5. Department of Pathology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL

6. National Cancer Institute, Bethesda, MD

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/108497801753131381

Reference30 articles.

1. Pharmacokinetics and toxicity of an yttrium‐90‐citc‐dtpa‐hmfg1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer

2. Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.

3. Intraperitoneal radioimmunotherapy for ovarian cancer: Pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodies

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sialyl-Tn glycan epitope as a target for pancreatic cancer therapies;Frontiers in Oncology;2024-09-13

2. Lutetium-177 radioisotope and therapeutic radiopharmaceuticals: Production, separation and purification, chelation labeling and clinical application;Chinese Science Bulletin;2024-04-12

3. CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies;Frontiers in Immunology;2023-10-03

4. Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors;Cancers;2023-07-08

5. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives;Cancers;2022-01-27